US Stock MarketDetailed Quotes

Sonoma Pharmaceuticals (SNOA)

Watchlist
  • 1.150
  • 0.0000.00%
Trading May 14 10:17 ET
3.99MMarket Cap-0.59P/E (TTM)

Sonoma Pharmaceuticals (SNOA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-235.22%-764K
-279.38%-635K
-120.94%-2.02M
96.33%-88K
-162.50%-95K
151.18%565K
128.76%354K
-324.19%-912K
61.02%-2.4M
106.23%152K
Net income from continuing operations
11.75%-819K
12.46%-534K
-8.57%-1.24M
28.50%-3.46M
27.27%-776K
-7.16%-928K
58.89%-610K
19.39%-1.14M
6.13%-4.84M
18.43%-1.07M
Depreciation and amortization
3.03%34K
2.86%36K
-7.69%36K
-21.59%138K
-24.39%31K
-26.67%33K
-22.22%35K
-13.33%39K
40.80%176K
20.59%41K
Deferred tax
410.53%59K
-27.27%48K
-23.77%93K
427.52%357K
193.53%188K
63.46%-19K
22.22%66K
35.56%122K
-194.59%-109K
-197.10%-201K
Other non cash items
----
----
-914.55%-448K
8.07%174K
----
----
----
-30.38%55K
-6.94%161K
----
Change In working capital
-104.23%-62K
-174.34%-672K
-456.52%-512K
46.25%2.48M
-82.77%198K
495.15%1.47M
777.67%904K
-111.33%-92K
187.72%1.69M
169.81%1.15M
-Change in receivables
-47.37%340K
-281.40%-78K
54.04%-216K
288.70%434K
2,488.89%215K
208.39%646K
-76.63%43K
-346.07%-470K
-5,650.00%-230K
93.23%-9K
-Change in inventory
87.06%-40K
181.25%208K
-471.93%-652K
-310.87%-388K
5.05%291K
37.70%-309K
-247.98%-256K
-149.57%-114K
--184K
70.99%277K
-Change in prepaid assets
-194.92%-392K
-101.40%-15K
-1,488.14%-819K
-1.90%1.09M
-182.17%-461K
-17.23%413K
720.61%1.08M
170.24%59K
461.76%1.11M
163.90%561K
-Change in payables and accrued expense
-39.27%416K
-1,758.33%-398K
34.58%646K
429.17%1.14M
-146.94%-46K
578.22%685K
104.81%24K
-6.98%480K
163.34%216K
116.53%98K
-Change in other current assets
-573.53%-161K
----
----
----
----
70.00%34K
----
----
----
----
-Change in other current liabilities
576.47%162K
-19.15%-56K
914.55%448K
-8.07%-174K
38.71%-38K
-70.00%-34K
---47K
30.38%-55K
6.94%-161K
21.52%-62K
-Change in other working capital
-1,348.39%-387K
259.46%59K
912.50%81K
-35.01%375K
-2.61%373K
-74.38%31K
-205.71%-37K
-78.95%8K
152.17%577K
1,335.48%383K
Cash from discontinued investing activities
Operating cash flow
-235.22%-764K
-279.38%-635K
-120.94%-2.02M
96.33%-88K
-162.50%-95K
151.18%565K
128.76%354K
-324.19%-912K
61.02%-2.4M
106.23%152K
Investing cash flow
Cash flow from continuing investing activities
-2,250.00%-47K
61.54%-10K
-2,020.00%-106K
-3,900.00%-80K
-361.11%-47K
-100.00%-2K
-1,200.00%-26K
70.59%-5K
99.22%-2K
121.95%18K
Net PPE purchase and sale
-2,250.00%-47K
61.54%-10K
-2,020.00%-106K
-3,900.00%-80K
-361.11%-47K
-100.00%-2K
-1,200.00%-26K
70.59%-5K
99.26%-2K
109.47%18K
Net other investing changes
----
----
----
----
----
----
----
----
36.36%15K
----
Cash from discontinued investing activities
Investing cash flow
-2,250.00%-47K
61.54%-10K
-2,020.00%-106K
-3,900.00%-80K
-361.11%-47K
-100.00%-2K
-1,200.00%-26K
70.59%-5K
99.22%-2K
121.95%18K
Financing cash flow
Cash flow from continuing financing activities
-70.34%210K
-104.29%-62K
-109.12%-58K
80.79%3.03M
-61.09%242K
-46.28%708K
1,219.38%1.44M
571.11%636K
-32.66%1.68M
-81.55%622K
Net issuance payments of debt
31.71%-56K
31.97%-83K
31.93%-81K
16.01%-404K
13.83%-81K
35.94%-82K
5.43%-122K
8.46%-119K
46.20%-481K
6.00%-94K
Net common stock issuance
-66.29%266K
--0
--0
72.53%3.08M
--0
-45.44%789K
--1.54M
15,060.00%748K
-37.80%1.78M
-88.04%343K
Proceeds from stock option exercised by employees
--0
-19.23%21K
228.57%23K
--82K
--49K
--0
--26K
--7K
--0
--0
Net other financing activities
----
----
----
-26.54%274K
----
----
----
----
-27.57%373K
----
Cash from discontinued financing activities
Financing cash flow
-70.34%210K
-104.29%-62K
-109.12%-58K
80.79%3.03M
-61.09%242K
-46.28%708K
1,219.38%1.44M
571.11%636K
-32.66%1.68M
-81.55%622K
Net cash flow
Beginning cash position
-25.58%3.04M
39.24%3.61M
71.80%5.37M
-18.12%3.13M
117.62%5.24M
90.83%4.08M
-26.95%2.59M
-18.12%3.13M
-48.35%3.82M
-8.66%2.41M
Current changes in cash
-147.29%-601K
-139.90%-707K
-675.44%-2.18M
495.30%2.86M
-87.37%100K
496.71%1.27M
230.10%1.77M
23.43%-281K
81.54%-724K
-6.71%792K
Effect of exchange rate changes
212.39%127K
148.41%137K
258.91%410K
-2,025.00%-616K
154.29%38K
-301.79%-113K
-528.89%-283K
-383.52%-258K
-90.72%32K
-120.77%-70K
End cash Position
-51.09%2.56M
-25.58%3.04M
39.24%3.61M
71.80%5.37M
71.80%5.37M
117.62%5.24M
90.83%4.08M
-26.95%2.59M
-18.12%3.13M
-18.12%3.13M
Free cash flow
-244.05%-811K
-296.65%-645K
-131.30%-2.12M
93.00%-168K
-183.53%-142K
150.95%563K
126.60%328K
-295.26%-917K
62.62%-2.4M
106.46%170K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -235.22%-764K-279.38%-635K-120.94%-2.02M96.33%-88K-162.50%-95K151.18%565K128.76%354K-324.19%-912K61.02%-2.4M106.23%152K
Net income from continuing operations 11.75%-819K12.46%-534K-8.57%-1.24M28.50%-3.46M27.27%-776K-7.16%-928K58.89%-610K19.39%-1.14M6.13%-4.84M18.43%-1.07M
Depreciation and amortization 3.03%34K2.86%36K-7.69%36K-21.59%138K-24.39%31K-26.67%33K-22.22%35K-13.33%39K40.80%176K20.59%41K
Deferred tax 410.53%59K-27.27%48K-23.77%93K427.52%357K193.53%188K63.46%-19K22.22%66K35.56%122K-194.59%-109K-197.10%-201K
Other non cash items ---------914.55%-448K8.07%174K-------------30.38%55K-6.94%161K----
Change In working capital -104.23%-62K-174.34%-672K-456.52%-512K46.25%2.48M-82.77%198K495.15%1.47M777.67%904K-111.33%-92K187.72%1.69M169.81%1.15M
-Change in receivables -47.37%340K-281.40%-78K54.04%-216K288.70%434K2,488.89%215K208.39%646K-76.63%43K-346.07%-470K-5,650.00%-230K93.23%-9K
-Change in inventory 87.06%-40K181.25%208K-471.93%-652K-310.87%-388K5.05%291K37.70%-309K-247.98%-256K-149.57%-114K--184K70.99%277K
-Change in prepaid assets -194.92%-392K-101.40%-15K-1,488.14%-819K-1.90%1.09M-182.17%-461K-17.23%413K720.61%1.08M170.24%59K461.76%1.11M163.90%561K
-Change in payables and accrued expense -39.27%416K-1,758.33%-398K34.58%646K429.17%1.14M-146.94%-46K578.22%685K104.81%24K-6.98%480K163.34%216K116.53%98K
-Change in other current assets -573.53%-161K----------------70.00%34K----------------
-Change in other current liabilities 576.47%162K-19.15%-56K914.55%448K-8.07%-174K38.71%-38K-70.00%-34K---47K30.38%-55K6.94%-161K21.52%-62K
-Change in other working capital -1,348.39%-387K259.46%59K912.50%81K-35.01%375K-2.61%373K-74.38%31K-205.71%-37K-78.95%8K152.17%577K1,335.48%383K
Cash from discontinued investing activities
Operating cash flow -235.22%-764K-279.38%-635K-120.94%-2.02M96.33%-88K-162.50%-95K151.18%565K128.76%354K-324.19%-912K61.02%-2.4M106.23%152K
Investing cash flow
Cash flow from continuing investing activities -2,250.00%-47K61.54%-10K-2,020.00%-106K-3,900.00%-80K-361.11%-47K-100.00%-2K-1,200.00%-26K70.59%-5K99.22%-2K121.95%18K
Net PPE purchase and sale -2,250.00%-47K61.54%-10K-2,020.00%-106K-3,900.00%-80K-361.11%-47K-100.00%-2K-1,200.00%-26K70.59%-5K99.26%-2K109.47%18K
Net other investing changes --------------------------------36.36%15K----
Cash from discontinued investing activities
Investing cash flow -2,250.00%-47K61.54%-10K-2,020.00%-106K-3,900.00%-80K-361.11%-47K-100.00%-2K-1,200.00%-26K70.59%-5K99.22%-2K121.95%18K
Financing cash flow
Cash flow from continuing financing activities -70.34%210K-104.29%-62K-109.12%-58K80.79%3.03M-61.09%242K-46.28%708K1,219.38%1.44M571.11%636K-32.66%1.68M-81.55%622K
Net issuance payments of debt 31.71%-56K31.97%-83K31.93%-81K16.01%-404K13.83%-81K35.94%-82K5.43%-122K8.46%-119K46.20%-481K6.00%-94K
Net common stock issuance -66.29%266K--0--072.53%3.08M--0-45.44%789K--1.54M15,060.00%748K-37.80%1.78M-88.04%343K
Proceeds from stock option exercised by employees --0-19.23%21K228.57%23K--82K--49K--0--26K--7K--0--0
Net other financing activities -------------26.54%274K-----------------27.57%373K----
Cash from discontinued financing activities
Financing cash flow -70.34%210K-104.29%-62K-109.12%-58K80.79%3.03M-61.09%242K-46.28%708K1,219.38%1.44M571.11%636K-32.66%1.68M-81.55%622K
Net cash flow
Beginning cash position -25.58%3.04M39.24%3.61M71.80%5.37M-18.12%3.13M117.62%5.24M90.83%4.08M-26.95%2.59M-18.12%3.13M-48.35%3.82M-8.66%2.41M
Current changes in cash -147.29%-601K-139.90%-707K-675.44%-2.18M495.30%2.86M-87.37%100K496.71%1.27M230.10%1.77M23.43%-281K81.54%-724K-6.71%792K
Effect of exchange rate changes 212.39%127K148.41%137K258.91%410K-2,025.00%-616K154.29%38K-301.79%-113K-528.89%-283K-383.52%-258K-90.72%32K-120.77%-70K
End cash Position -51.09%2.56M-25.58%3.04M39.24%3.61M71.80%5.37M71.80%5.37M117.62%5.24M90.83%4.08M-26.95%2.59M-18.12%3.13M-18.12%3.13M
Free cash flow -244.05%-811K-296.65%-645K-131.30%-2.12M93.00%-168K-183.53%-142K150.95%563K126.60%328K-295.26%-917K62.62%-2.4M106.46%170K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More